ARTICLE | Clinical News
LBS-neurons: Began Phase IIb trial
May 14, 2001 7:00 AM UTC
Layton BioScience Inc., Sunnyvale, Calif. Product: LBS-neurons Business: Neurological, Gene/Cell therapy Therapeutic category: Cell replacement Target: Basal ganglia region of the brain Description: H...